You are here

Article info

Article menu
Download PDFPDF
Commentary
Does suppression of HBV replication by antiviral therapy confer the same benefit as host immune control of HBV?

Authors

  1. Correspondence to Dr Anna S Lok, Division of Gastroenterology, University of Michigan Health System, 3912 Taubman Center, SPC 5362, Ann Arbor, MI 48109, USA; aslok{at}umich.edu
View Full Text

Citation

Yapali S, Lok AS
Does suppression of HBV replication by antiviral therapy confer the same benefit as host immune control of HBV?
Gut 2014;63:1833-1834.

Publication history

  • Received March 5, 2014
  • Revised March 9, 2014
  • Accepted March 10, 2014
  • First published April 1, 2014.
Online issue publication 
April 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions